Consolidated Investment Group LLC Amgen Inc Transaction History

Consolidated Investment Group LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 27, 2021	SELL	$212.27 - $248.7 $2.96 Million - $3.47 Million	-13,934 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $494,525 - $606,850	-2,500 Reduced 15.21%	13,934 $3.29 Million
Q3 2019 Oct 21, 2019	SELL	$174.11 - $208.62 $1.04 Million - $1.25 Million	-6,000 Reduced 26.75%	16,434 $3.18 Million
Q4 2018 Jan 22, 2019	BUY	$178.4 - $208.25 $267,600 - $312,375	1,500 Added 7.17%	22,434 $4.37 Million
Q2 2018 Jul 19, 2018	BUY	$166.05 - $186.51 $630,990 - $708,738	3,800 Added 22.18%	20,934 $3.86 Million
Q3 2017 Oct 24, 2017	BUY	$167.29 - $191.0 $2.87 Million - $3.27 Million	17,134	17,134 $3.2 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Consolidated Investment Group LLC, based on Form 13F filings with the SEC.

Stay updated on Consolidated Investment Group LLC with notifications on news.